We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Jardine Cycle and Carriage Ltd | TG:CYC | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.70 | 19.50 | 19.80 | 19.70 | 19.70 | 19.70 | 55 | 16:13:18 |
RNS Number:4898M CYC Holdings PLC 19 June 2003 19 June 2003 CYC Holdings plc Interim Results to 30 April 2003. Chairman's Statement I have pleasure in announcing the Group's unaudited interim financial statements for the six months ended 30 April 2003. The preceding six months have seen considerable fluctuations on the major stock markets, falls being recorded in the early period, followed by a gradual and as yet uncertain recovery, being frequently referred to as "the "Baghdad bounce". Chinese equity markets largely tracked western exchanges and the uncertainty surrounding the commencement of hostilities in the Gulf caused investors to extend their already cautious position to that of reducing their exposures. This led to further declines in values. However once the engagement in the war against Saddam Hussein took place, at least one uncertainty was removed from investors' minds. Given this backdrop, market sentiment was reflected by a downturn in general commercial activity in China. Investment decisions were postponed until there was less uncertainty on the world stage. Just when things were showing signs of improvement, SARS emerged. The continuing economic impact on China has everyone guessing. Economists and pundits alike are forecasting a reduction of GNP for this year between 2 - 4%, a wide-ranging guess. No one knows the short-term effect let alone what may happen in the longer term. Certain sectors, namely manufacturing and agriculture have been largely unaffected. However a slowdown in retailing and Foreign Direct Investment decisions have been detected. Certainly, travel restrictions published by the WHO have severely hampered foreign business travel and tourism, leading to delays and possible cancellation of projects. Domestic travel restrictions were an even more effective brake on commercial activity. With the sharp decline in new cases there is evidence that the disease is being brought under control. It is hoped that business life will return to normal in the next 3 months. Your company like all others with Chinese activities has been affected by this situation. So far the consequence has been confined to time induced delays not cancellation. We have a number of projects under development, of which two are approaching completion. One is being scheduled for flotation; the other is in the final stages of due diligence investigation. With the anticipated lifting of travel restrictions to Beijing in the next two months, these projects should be advanced and the benefits of your company's endeavours should be seen coming through in the second half of the year. In the meantime, to mitigate overheads, the Directors have been actively pursuing revenue-generating consultancy related to our core activities. One such strategy is the rehabilitation of UK shell companies in anticipation that they can subsequently be used as reverse take-over vehicles for Chinese businesses. Two UK shell companies are in the final stages of restoration and your company is scheduled to receive accrued fees in the second half. In the meantime, strenuous efforts have been made to husband the original cash raised on flotation. The strength of company's balance sheet is evidenced by the preservation of over #1.2 million of capital and reserves. It could be said that world events have not been kind to us, but this is largely the same for all companies in our fields of activity. Your company's pursuit of the corporate development of Chinese businesses is, by necessity, a long-term process, especially in China. In reality it should be recognised that having an extended developmental time frame, political, economic and now health induced turbulence would be bound to affect us. Yours sincerely, The Viscount Torrington For further information please contact Ken Rees at Winningtons on 0117 317 9477 or 07802 466567 CONSOLIDATED PROFIT AND LOSS ACCOUNT for the six months ended 30 April 2003 6 months ended 30 April 2002 # # OTHER OPERATING INCOME 14,635 43,289 OPERATING EXPENSES (140,343) (144,608) OPERATING LOSS (125,708) (101,319) Interest payable - (4) LOSS ON ORDINARY ACTIVITIES BEFORE TAXATION (125,708) (101,323) RETAINED LOSS FOR THE PERIOD (125,708) (101,323) LOSSES BROUGHT FORWARD (2,523,058) (2,264,133) LOSSES CARRIED FORWARD (2,648,766) (2,365,456) EARNINGS PER SHARE (0.04 p) (0.03 p) The loss for the period has been calculated on the historical cost basis and contains all the gains and losses recognised in the period. CONSOLIDATED BALANCE SHEET at 30 April 2003 30 April 2002 # # # # FIXED ASSETS Intangible assets - - Tangible assets 1,460 1,156 1,460 1,156 CURRENT ASSETS Investments 86,727 530,624 Debtors 51,844 24,564 Cash at bank and in hand 1,114,837 972,680 1,253,408 1,527,868 CREDITORS Amounts falling due within one year (33,507) (24,353) NET CURRENT ASSETS 1,219,901 1,503,515 NET ASSETS #1,221,361 #1,504,671 CAPITAL AND RESERVES Called-up share capital 3,080,000 3,080,000 Share premium account 790,127 790,127 Profit and loss account (2,648,766) (2,365,456) #1,221,361 #1,504,671 This information is provided by RNS The company news service from the London Stock Exchange END IR UWAVROKRNAAR
1 Year Jardine Cycle and Carriage Chart |
1 Month Jardine Cycle and Carriage Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions